| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The Company had the following anti-dilutive
common stock equivalents as calculated under the treasury stock method:
| |
|
For the Three Months Ended
September 30,
|
|
|
For the Nine Months Ended
September 30,
|
|
| |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| Convertible preferred stock, Series A (a) |
|
|
28,724 |
|
|
|
26,687 |
|
|
|
28,724 |
|
|
|
26,687 |
|
| Convertible preferred stock, Series A-1 (a) |
|
|
18,173 |
|
|
|
15,746 |
|
|
|
18,173 |
|
|
|
15,746 |
|
| Common stock warrants |
|
|
1,086,319 |
|
|
|
138,102 |
|
|
|
1,086,319 |
|
|
|
819,925 |
|
| Restricted stock units |
|
|
322,921 |
|
|
|
12,045 |
|
|
|
322,921 |
|
|
|
322,921 |
|
| Options |
|
|
46,490 |
|
|
|
— |
|
|
|
46,490 |
|
|
|
— |
|
| Total potentially dilutive shares |
|
|
1,502,627 |
|
|
|
192,580 |
|
|
|
1,502,627 |
|
|
|
1,185,279 |
|
| |
(a) |
Dilutive effect of convertible securities are included in diluted EPS by application of the if-converted method. |
|